The Relationship between EGFR Mutations and Response and Prognosis of Tyrosine Kinase Inhibitors in Advanced Non-small-cell Lung Cancer
Background and objectives It has been proven that epigermal growth factor receptor (EGFR) signal pathway plaied an important role in the oncogenesis and development of non-small cell lung cancer (NSCLC). EGFR tyrosine kinase inhibitors (EGFR-TKIs) are currently investigated in the treatment of NSCLC...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
格式: | 文件 |
语言: | zho |
出版: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2008-04-01
|
丛编: | Chinese Journal of Lung Cancer |
主题: | |
在线阅读: | http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2008.02.016&path%5B%5D=51 |